SCHEMBL971749

SCHEMBL971749

CCCCCCCCCCOC(=O)C(C)(CCCCCC)C(C)CCCCC

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.43
EPHX1 P07099 1/20 0.41
TSHR P16473 3/20 0.40
ZDHHC7 Q9NXF8 1/20 0.39
HCAR2 Q8TDS4 1/20 0.38
RAD52 P43351 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
FAAH O00519 2/20 0.38
MEN1 O00255 1/20 0.38
MAPT P10636 1/20 0.38
KMT2A Q03164 1/20 0.38
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CA2 P00918 1/20 0.38
LMNA P02545 2/20 0.37
ALDH1A1 P00352 1/20 0.37
USP2 O75604 1/20 0.37
ACE2 Q9BYF1 1/20 0.37
ACHE P22303 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28811351 0.88 NAAA (0.41) NAAAEPHX1TSHRZDHHC7HCAR2
SCHEMBL8366231 0.84 NAAA (0.43) NAAAEPHX1TSHRZDHHC7HCAR2
SCHEMBL9346321 0.84 NAAA (0.46) NAAAEPHX1TSHRZDHHC7HCAR2
SCHEMBL12504158 0.84 GPR84 (0.42) ZDHHC7FAAHMEN1MAPTKMT2A
SCHEMBL12504534 0.84 GPR84 (0.42) ZDHHC7FAAHMEN1MAPTKMT2A
SCHEMBL12504497 0.84 GPR84 (0.42) ZDHHC7FAAHMEN1MAPTKMT2A
SCHEMBL26601421 0.83 NAAA (0.44) NAAAEPHX1TSHRZDHHC7HCAR2
SCHEMBL2982999 0.83 NAAA (0.44) NAAAEPHX1TSHRZDHHC7HCAR2
SCHEMBL12504540 0.81 NAAA (0.43) NAAAEPHX1TSHRZDHHC7HCAR2
SCHEMBL12504501 0.81 NAAA (0.43) NAAAEPHX1TSHRZDHHC7HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120321576-A1 SUNSCREEN COMPOSITION SHISEIDO COMPANY, LTD. (JP) 2012-12-20 US claimed
WO-2024059119-A2 COMPOUNDS AND THEIR USE IN FILTERING ULTRAVIOLET AND/OR HIGH-ENERGY VISIBLE LIGHT SOLIOME, INC. (US) 2024-03-21 WO disclosed
EP-4301790-A1 SUNSCREENS DERIVED FROM KYNURENINES AND OTHER UV-ABSORBING OXIDIZED AMINO ACIDS BOUND TO PEPTIDES OR POLYMERS The Trustees Of Princeton University (US) 2024-01-10 EP disclosed
EP-3145473-B1 SUNSCREEN PRODUCTS IN WHICH EXCESSIVE WHITENESS DUE TO TITANIUM DIOXIDE AND ZINC OXIDE IS VISUALLY MASKED UPON SKIN APPLICATION SHISEIDO CO LTD (JP) 2019-05-08 EP disclosed
EP-3145473-A1 SUNSCREEN PRODUCTS IN WHICH EXCESSIVE WHITENESS DUE TO TITANIUM DIOXIDE AND ZINC OXIDE IS VISUALLY MASKED UPON SKIN APPLICATION Shiseido Company Ltd. (JP) 2017-03-29 EP disclosed
EP-2243465-B1 WATER-IN-OIL EMULSION TYPE SUNSCREEN COSMETIC SHISEIDO CO LTD (JP) 2016-01-20 EP disclosed
WO-2015178007-A1 SUNSCREEN PRODUCTS IN WHICH EXCESSIVE WHITENESS DUE TO TITANIUM DIOXIDE AND ZINC OXIDE IS VISUALLY MASKED UPON SKIN APPLICATION SHISEIDO COMPANY, LTD. (JP) 2015-11-26 WO disclosed
US-20150328088-A1 SUNSCREEN PRODUCTS IN WHICH EXCESSIVE WHITENESS DUE TO TITANIUM DIOXIDE AND ZINC OXIDE IS VISUALLY MASKED UPON SKIN APPLICATION SHISEIDO COMPANY, LTD. (JP) 2015-11-19 US disclosed
US-9186305-B1 Sunscreen products in which excessive whiteness due to titanium dioxide and zinc oxide is visually masked upon skin application SHISEIDO COMPANY, LTD. (JP) 2015-11-17 US disclosed
US-9044624-B2 Sunscreen composition SHISEIDO COMPANY, LTD. (JP) 2015-06-02 US disclosed
EP-1739096-A1 PECTIN ORIGINATING IN PLANT CELL Mitsui Chemicals, Inc. (JP) 2007-01-03 EP disclosed
US-20060099161-A1 Skin preparations for external use SHISEIDO COMPANY, LTD. (JP) 2006-05-11 US disclosed
US-20050180931-A1 External preparations for skin SHISEIDO COMPANY, LTD. (JP) 2005-08-18 US disclosed
EP-1557159-A1 SKIN PREPARATIONS FOR EXTERNAL USE SHISEIDO COMPANY LIMITED (JP) 2005-07-27 EP disclosed
EP-1550429-A1 EXTERNAL PREPARATIONS FOR SKIN SHISEIDO COMPANY, LTD. (JP) 2005-07-06 EP disclosed
US-20040197361-A1 External preparation for the skin SHISEIDO COMPANY, LTD. (JP) 2004-10-07 US disclosed
EP-1430905-A1 EXTERNAL PREPARATION FOR THE SKIN SHISEIDO COMPANY LIMITED (JP) 2004-06-23 EP disclosed
US-6607736-B2 Endermic liniment comprising diethoxy ethyl succinate and humectant SHISEIDO COMPANY, LTD. (JP) 2003-08-19 US disclosed
US-20030091603-A1 Skin preparations for external use SHISEIDO COMPANY, LTD. (JP) 2003-05-15 US disclosed
EP-1153602-A1 SKIN PREPARATIONS FOR EXTERNAL USE SHISEIDO COMPANY LIMITED (JP) 2001-11-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030091603-A1 Skin preparations for external use CUTA, POLR1C, ACMSD NAAA 1925/4885EPHX1 824/4885TSHR 4325/4885
US-20040197361-A1 External preparation for the skin CUTA, DDOST, DSG1 NAAA 1014/4885EPHX1 379/4885TSHR 3564/4885
US-20050180931-A1 External preparations for skin CUTA, HRH1, CYP24A1 NAAA 327/4885EPHX1 101/4885TSHR 3047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.